EP0964683A4 - Leukotriene antagoniste zur behandlung von plattenepithelkarzinom der mundhöhle - Google Patents

Leukotriene antagoniste zur behandlung von plattenepithelkarzinom der mundhöhle

Info

Publication number
EP0964683A4
EP0964683A4 EP97949709A EP97949709A EP0964683A4 EP 0964683 A4 EP0964683 A4 EP 0964683A4 EP 97949709 A EP97949709 A EP 97949709A EP 97949709 A EP97949709 A EP 97949709A EP 0964683 A4 EP0964683 A4 EP 0964683A4
Authority
EP
European Patent Office
Prior art keywords
oral
leukotriene antagonists
spinocellular epithelioma
spinocellular
epithelioma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97949709A
Other languages
English (en)
French (fr)
Other versions
EP0964683A1 (de
Inventor
Jerome H Fleisch
William T Jackson
Jason S Sawyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of EP0964683A1 publication Critical patent/EP0964683A1/de
Publication of EP0964683A4 publication Critical patent/EP0964683A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP97949709A 1996-12-13 1997-12-02 Leukotriene antagoniste zur behandlung von plattenepithelkarzinom der mundhöhle Withdrawn EP0964683A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3426996P 1996-12-13 1996-12-13
US34269P 1996-12-13
US4087497P 1997-03-21 1997-03-21
US40874P 1997-03-21
PCT/US1997/021953 WO1998025615A1 (en) 1996-12-13 1997-12-02 Leukotriene antagonists for oral squamous cell carcinoma

Publications (2)

Publication Number Publication Date
EP0964683A1 EP0964683A1 (de) 1999-12-22
EP0964683A4 true EP0964683A4 (de) 2002-08-14

Family

ID=26710754

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97949709A Withdrawn EP0964683A4 (de) 1996-12-13 1997-12-02 Leukotriene antagoniste zur behandlung von plattenepithelkarzinom der mundhöhle

Country Status (14)

Country Link
EP (1) EP0964683A4 (de)
JP (1) JP2001509142A (de)
KR (1) KR20000069452A (de)
CN (1) CN1245429A (de)
AU (1) AU726215B2 (de)
CA (1) CA2274855A1 (de)
EA (1) EA002742B1 (de)
IL (1) IL130304A0 (de)
NO (1) NO992846L (de)
NZ (1) NZ335922A (de)
PL (1) PL334241A1 (de)
TR (1) TR199901307T2 (de)
UA (1) UA47505C2 (de)
WO (1) WO1998025615A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004505047A (ja) 2000-07-28 2004-02-19 キャンサー・リサーチ・テクノロジー・リミテッド 複合治療による癌治療
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
US8093253B2 (en) * 2008-03-06 2012-01-10 Hoffmann-La Roche Inc. Leukotriene B4 inhibitors
KR101898879B1 (ko) 2014-03-05 2018-09-14 재단법인 진안홍삼연구소 홍삼 가공 추출물을 유효성분으로 함유하는 구강편평세포암의 예방, 개선 또는 치료를 위한 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260655A2 (de) * 1986-09-16 1988-03-23 Sumitomo Pharmaceuticals Company, Limited Derivate von ungesättigter Fettsäure und deren Produktion
EP0544488A2 (de) * 1991-11-25 1993-06-02 Eli Lilly And Company Substituierte Phenylphenol-Leukotrienantagonisten

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30449A (en) * 1991-11-25 1997-05-28 Lilly Co Eli Substituted phenyl phenol leukotriene antagonists

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260655A2 (de) * 1986-09-16 1988-03-23 Sumitomo Pharmaceuticals Company, Limited Derivate von ungesättigter Fettsäure und deren Produktion
EP0544488A2 (de) * 1991-11-25 1993-06-02 Eli Lilly And Company Substituierte Phenylphenol-Leukotrienantagonisten

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9825615A1 *

Also Published As

Publication number Publication date
AU726215B2 (en) 2000-11-02
CN1245429A (zh) 2000-02-23
AU7845198A (en) 1998-07-03
UA47505C2 (uk) 2002-07-15
JP2001509142A (ja) 2001-07-10
NZ335922A (en) 2000-12-22
EA002742B1 (ru) 2002-08-29
IL130304A0 (en) 2000-06-01
TR199901307T2 (xx) 1999-08-23
EA199900543A1 (ru) 2000-02-28
KR20000069452A (ko) 2000-11-25
PL334241A1 (en) 2000-02-14
CA2274855A1 (en) 1998-06-18
NO992846D0 (no) 1999-06-11
WO1998025615A1 (en) 1998-06-18
EP0964683A1 (de) 1999-12-22
NO992846L (no) 1999-06-11

Similar Documents

Publication Publication Date Title
GB9718913D0 (en) Substituted oxindole derivatives
HU9603082D0 (en) Neurokinine (tachykinine) antagonists
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
HRP980303B1 (en) Benzimidazole derivatives
EP0826311A4 (de) Orale zusammensetzung für tiere
DK0829428T3 (da) Beholderfremføringsapparat
IL133674A0 (en) Benzimidazole derivatives
PL332416A1 (en) Substituted heterocyclic compounds as anticarcinogenic agents
ZA977326B (en) Tetrahydroquinoline derivatives
IL127432A0 (en) Substituted benzimidazole derivatives
NO971755D0 (no) Fôr for smolt
HU9503191D0 (en) Adhesion-receptor antagonists
HU9600005D0 (en) Novel substituted benzimidazoles
PL344694A1 (en) Tetrahydroquinoline derivatives as glycine antagonists
EP0986553A4 (de) Dihydropyrimidon-derivate als npy-antagonisten
EP0964683A4 (de) Leukotriene antagoniste zur behandlung von plattenepithelkarzinom der mundhöhle
EG24161A (en) Carbostyril derivatives
HUP9903910A3 (en) Insect-repellent formulations
GB9716101D0 (en) Fused heterocyclic compounds
ZA954129B (en) Novel substituted benzimidazoles
HU9603342D0 (en) Quinoline derivatives as leukotriene antagonists
KR970051155U (ko) 목수용 먹줄통
GB9711030D0 (en) Quinoline leukrotriene antagonists
SI1086093T1 (sl) Derivati tetrahidrokinolina kot antagonisti glicina
SE9700389D0 (sv) Vattenpipa "Karlsborgspipan"

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990609

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 19990609;LT PAYMENT 19990609;LV PAYMENT 19990609;RO PAYMENT 19990609;SI PAYMENT 19990609

A4 Supplementary search report drawn up and despatched

Effective date: 20020627

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 31/495 A, 7A 61K 31/50 B, 7A 61K 31/445 B, 7A 61K 31/44 B, 7A 61K 31/41 B, 7A 61K 31/275 B, 7A 61K 31/19 B, 7A 61K 31/535 B, 7A 61K 31/34 B, 7A 61K 31/35 B

17Q First examination report despatched

Effective date: 20030714

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050119